141 related articles for article (PubMed ID: 7427069)
1. Isolated limb perfusion with melphalan in the treatment of malignant melanoma.
Bulman AS; Jamieson CW
Br J Surg; 1980 Sep; 67(9):660-2. PubMed ID: 7427069
[TBL] [Abstract][Full Text] [Related]
2. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic isolation-perfusion as the primary therapy for invasive malignant melanoma of the limbs.
McBride CM; Sugarbaker EV; Hickey RC
Ann Surg; 1975 Sep; 182(3):316-24. PubMed ID: 1164059
[TBL] [Abstract][Full Text] [Related]
4. [Adjuvant regional isolation perfusion of the extremities of patients with stage I melanoma thicker than 1.5 mm].
Kroon BB; Schraffordt Koops H
Ned Tijdschr Geneeskd; 1990 Oct; 134(42):2042-7. PubMed ID: 2234177
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant regional isolated perfusion with melphalan for patients with Clark V melanoma of the extremities.
Vrouenraets BC; Kroon BB; Klaase JM; Van Geel BN; Eggermont AM; Franklin HR
J Surg Oncol; 1993 Apr; 52(4):249-54. PubMed ID: 8468989
[TBL] [Abstract][Full Text] [Related]
6. Improved survival rates of patients with acral lentiginous melanoma treated with hyperthermic isolation perfusion, wide excision, and regional lymphadenectomy.
Fletcher JR; White CR; Fletcher WS
Am J Surg; 1986 May; 151(5):593-8. PubMed ID: 3518512
[TBL] [Abstract][Full Text] [Related]
7. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities--long-term follow-up of a randomised trial.
Olofsson Bagge R; Mattsson J; Hafström L
Int J Hyperthermia; 2014 Aug; 30(5):295-8. PubMed ID: 25144818
[TBL] [Abstract][Full Text] [Related]
8. Survival after regional perfusion for limb melanoma.
Cox KR
Aust N Z J Surg; 1975 Feb; 45(1):32-6. PubMed ID: 808204
[TBL] [Abstract][Full Text] [Related]
9. Hypoxic pelvic and limb perfusion with melphalan and mitomycin C for recurrent limb melanoma: a pilot study.
Guadagni S; Santinami M; Patuzzo R; Pilati PL; Miotto D; Deraco M; Rossi CR; Fiorentini G; Di Filippo F; Valenti M; Amicucci G
Melanoma Res; 2003 Feb; 13(1):51-8. PubMed ID: 12569285
[TBL] [Abstract][Full Text] [Related]
10. Regional chemotherapy for melanoma. A 35-year experience.
Krementz ET; Carter RD; Sutherland CM; Muchmore JH; Ryan RF; Creech O
Ann Surg; 1994 Oct; 220(4):520-34; discussion 534-5. PubMed ID: 7944662
[TBL] [Abstract][Full Text] [Related]
11. Controversies concerning adjuvant regional isolated perfusion for stage I melanoma of the extremities.
Schraffordt Koops H; Kroon BB; Oldhoff J; Hoekstra HJ
World J Surg; 1992; 16(2):241-5. PubMed ID: 1561805
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593.
Koops HS; Vaglini M; Suciu S; Kroon BB; Thompson JF; Göhl J; Eggermont AM; Di Filippo F; Krementz ET; Ruiter D; Lejeune FJ
J Clin Oncol; 1998 Sep; 16(9):2906-12. PubMed ID: 9738557
[TBL] [Abstract][Full Text] [Related]
13. Survival and regional disease control after isolation-perfusion for invasive stage I melanoma of the extremities.
Sugarbaker EV; McBride CM
Cancer; 1976 Jan; 37(1):188-98. PubMed ID: 1247954
[TBL] [Abstract][Full Text] [Related]
14. Effective therapy: repeat limb perfusion for recurrent melanoma.
Krementz ET
J Am Coll Surg; 1996 Jun; 182(6):547-8. PubMed ID: 8646356
[No Abstract] [Full Text] [Related]
15. Prophylactic hyperthermic limb perfusion in stage I melanoma.
Krige JE; King HS; Strover RM
Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834
[TBL] [Abstract][Full Text] [Related]
16. Regional isolated perfusion of extremities for melanoma: a 20-year experience with drugs other than L-phenylalanine mustard.
Ariyan S; Poo WJ; Bolognia J
Plast Reconstr Surg; 1997 Apr; 99(4):1023-9. PubMed ID: 9091898
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan.
Klaase JM; Kroon BB; van Geel AN; Eggermont AM; Franklin HR; Hart AA
Surgery; 1994 Jan; 115(1):39-45. PubMed ID: 8284759
[TBL] [Abstract][Full Text] [Related]
18. Isolation perfusion. An adjunct to surgical excision in the primary treatment of melanoma of the extremities.
Alrich EM; Manwaring JL; Horsley JS
Am J Surg; 1971 May; 121(5):583-5. PubMed ID: 5557770
[No Abstract] [Full Text] [Related]
19. Chemotherapy by regional perfusion for limb melanoma.
Krementz ET; Carter RD; Sutherland CM; Muchmore JH
Am Surg; 1987 Mar; 53(3):133-40. PubMed ID: 3103506
[TBL] [Abstract][Full Text] [Related]
20. [Surgical treatment and regional chemotherapy in melanoma of the extremities].
Henneking K; Binder J; Weyers W; Schwemmle K
Chirurg; 1993 Feb; 64(2):134-8. PubMed ID: 8462350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
